201 related articles for article (PubMed ID: 24475249)
1. Uridine prevents fenofibrate-induced fatty liver.
Le TT; Urasaki Y; Pizzorno G
PLoS One; 2014; 9(1):e87179. PubMed ID: 24475249
[TBL] [Abstract][Full Text] [Related]
2. Uridine prevents tamoxifen-induced liver lipid droplet accumulation.
Le TT; Urasaki Y; Pizzorno G
BMC Pharmacol Toxicol; 2014 May; 15():27. PubMed ID: 24887406
[TBL] [Abstract][Full Text] [Related]
3. Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice.
Huang J; Jia Y; Fu T; Viswakarma N; Bai L; Rao MS; Zhu Y; Borensztajn J; Reddy JK
FASEB J; 2012 Feb; 26(2):628-38. PubMed ID: 22009939
[TBL] [Abstract][Full Text] [Related]
4. PPARα agonist WY-14,643 induces the PLA2/COX-2/ACOX1 pathway to enhance peroxisomal lipid metabolism and ameliorate alcoholic fatty liver in mice.
Xu Y; Denning KL; Lu Y
Biochem Biophys Res Commun; 2022 Jul; 613():47-52. PubMed ID: 35526488
[TBL] [Abstract][Full Text] [Related]
5. Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice.
Aasum E; Khalid AM; Gudbrandsen OA; How OJ; Berge RK; Larsen TS
J Mol Cell Cardiol; 2008 Jan; 44(1):201-9. PubMed ID: 17931655
[TBL] [Abstract][Full Text] [Related]
6. Evidence of oxidative stress in very long chain fatty acid--treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins.
Baarine M; Andréoletti P; Athias A; Nury T; Zarrouk A; Ragot K; Vejux A; Riedinger JM; Kattan Z; Bessede G; Trompier D; Savary S; Cherkaoui-Malki M; Lizard G
Neuroscience; 2012 Jun; 213():1-18. PubMed ID: 22521832
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of bicyclol on tetracycline-induced fatty liver in mice.
Yu HY; Wang BL; Zhao J; Yao XM; Gu Y; Li Y
Toxicology; 2009 Jul; 261(3):112-8. PubMed ID: 19427351
[TBL] [Abstract][Full Text] [Related]
8. Alteration of 20:5n-3 and 22:6n-3 fat contents and liver peroxisomal activities in fenofibrate-treated rainbow trout.
Du ZY; Demizieux L; Degrace P; Gresti J; Moindrot B; Liu YJ; Tian LX; Cao JM; Clouet P
Lipids; 2004 Sep; 39(9):849-55. PubMed ID: 15669760
[TBL] [Abstract][Full Text] [Related]
9. Fenofibrate, a peroxisome proliferator-activated receptor α ligand, prevents abnormal liver function induced by a fasting-refeeding process.
Lee JN; Dutta RK; Kim SG; Lim JY; Kim SJ; Choe SK; Yoo KW; Song SR; Park DS; So HS; Park R
Biochem Biophys Res Commun; 2013 Dec; 442(1-2):22-7. PubMed ID: 24211584
[TBL] [Abstract][Full Text] [Related]
10. Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype.
Hashimoto T; Fujita T; Usuda N; Cook W; Qi C; Peters JM; Gonzalez FJ; Yeldandi AV; Rao MS; Reddy JK
J Biol Chem; 1999 Jul; 274(27):19228-36. PubMed ID: 10383430
[TBL] [Abstract][Full Text] [Related]
11. Fenofibrate simultaneously induces hepatic fatty acid oxidation, synthesis, and elongation in mice.
Oosterveer MH; Grefhorst A; van Dijk TH; Havinga R; Staels B; Kuipers F; Groen AK; Reijngoud DJ
J Biol Chem; 2009 Dec; 284(49):34036-44. PubMed ID: 19801551
[TBL] [Abstract][Full Text] [Related]
12. Regulation of rat liver apolipoprotein A-I, apolipoprotein A-II and acyl-coenzyme A oxidase gene expression by fibrates and dietary fatty acids.
Berthou L; Saladin R; Yaqoob P; Branellec D; Calder P; Fruchart JC; Denèfle P; Auwerx J; Staels B
Eur J Biochem; 1995 Aug; 232(1):179-87. PubMed ID: 7556148
[TBL] [Abstract][Full Text] [Related]
13. Acetyl-CoA Derived from Hepatic Peroxisomal β-Oxidation Inhibits Autophagy and Promotes Steatosis via mTORC1 Activation.
He A; Chen X; Tan M; Chen Y; Lu D; Zhang X; Dean JM; Razani B; Lodhi IJ
Mol Cell; 2020 Jul; 79(1):30-42.e4. PubMed ID: 32473093
[TBL] [Abstract][Full Text] [Related]
14. Participation of peroxisomes in the metabolism of xenobiotic acyl compounds: comparison between peroxisomal and mitochondrial beta-oxidation of omega-phenyl fatty acids in rat liver.
Yamada J; Ogawa S; Horie S; Watanabe T; Suga T
Biochim Biophys Acta; 1987 Sep; 921(2):292-301. PubMed ID: 3651489
[TBL] [Abstract][Full Text] [Related]
15. De novo expression of uncoupling protein 3 is associated to enhanced mitochondrial thioesterase-1 expression and fatty acid metabolism in liver of fenofibrate-treated rats.
Lanni A; Mancini FP; Sabatino L; Silvestri E; Franco R; De Rosa G; Goglia F; Colantuoni V
FEBS Lett; 2002 Aug; 525(1-3):7-12. PubMed ID: 12163152
[TBL] [Abstract][Full Text] [Related]
16. Rosiglitazone and fenofibrate exacerbate liver steatosis in a mouse model of obesity and hyperlipidemia. A transcriptomic and metabolomic study.
Rull A; Geeraert B; Aragonès G; Beltrán-Debón R; Rodríguez-Gallego E; García-Heredia A; Pedro-Botet J; Joven J; Holvoet P; Camps J
J Proteome Res; 2014 Mar; 13(3):1731-43. PubMed ID: 24479691
[TBL] [Abstract][Full Text] [Related]
17. The role of fenofibrate in clinical practice.
Zambon A; Cusi K
Diab Vasc Dis Res; 2007 Sep; 4 Suppl 3():S15-20. PubMed ID: 17935056
[TBL] [Abstract][Full Text] [Related]
18. Administration of Fenofibrate Markedly Elevates Fabp3 in Rat Liver and Plasma and Confounds Its Use as a Preclinical Biomarker of Cardiac and Muscle Toxicity.
Kochansky CJ; Lyman MJ; Fauty SE; Vlasakova K; D'mello AP
Lipids; 2018 Oct; 53(10):947-960. PubMed ID: 30592062
[TBL] [Abstract][Full Text] [Related]
19. 3,5-Diiodo-L-thyronine modulates the expression of genes of lipid metabolism in a rat model of fatty liver.
Grasselli E; Voci A; Demori I; Canesi L; De Matteis R; Goglia F; Lanni A; Gallo G; Vergani L
J Endocrinol; 2012 Feb; 212(2):149-58. PubMed ID: 22107956
[TBL] [Abstract][Full Text] [Related]
20. Disruption of uridine homeostasis links liver pyrimidine metabolism to lipid accumulation.
Le TT; Ziemba A; Urasaki Y; Hayes E; Brotman S; Pizzorno G
J Lipid Res; 2013 Apr; 54(4):1044-57. PubMed ID: 23355744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
